Ajou University repository

  • Results/Page
  • Sort by
  • In order
  • Authors/record

Showing results 1 to 10 of 570 (Search time: 0.0 seconds).

Impact of metformin on statin-associated myopathy risks in dyslipidemia patientsoa mark
  • Bak, Keunhyeong;
  • Moon, Suhyeon;
  • Ko, Minjung;
  • Choi, Yeo Jin;
  • Shin, Sooyoung
  • 2023-08-01
  • Pharmacology Research and Perspectives, Vol.11
  • John Wiley and Sons Inc
Galangin 3-benzyl-5-methylether derivatives function as an adiponectin synthesis-promoting peroxisome proliferator-activated receptor γ partial agonist
  • Ko, Hyejin;
  • Jang, Hongjun;
  • An, Seungchan;
  • Park, In Guk;
  • Ahn, Sungjin;
  • Gong, Junpyo;
  • Hwang, Seok Young;
  • Oh, Soyeon;
  • Kwak, Soo Yeon;
  • Choi, Won Jun;
  • Kim, Hyoungsu;
  • Noh, Minsoo
  • 2022-01-15
  • Bioorganic and Medicinal Chemistry, Vol.54
  • Elsevier Ltd
MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolismoa mark
  • 2019-12-01
  • Scientific Reports, Vol.9
  • Nature Publishing Group
Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patientsoa mark
  • 2023-12-01
  • Scientific Reports, Vol.13
  • Nature Research
Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancyoa mark
  • 2019-04-01
  • International Journal of Cancer, Vol.144, pp.1530-1539
  • Wiley-Liss Inc.
A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese miceoa mark
  • Han, Ji Hye;
  • Shin, Hanho;
  • Park, Ju Young;
  • Rho, Jun Gi;
  • Son, Dong Hwee;
  • Kim, Ki Woo;
  • Seong, Je Kyung;
  • Yoon, Sung Hwa;
  • Kim, Wook
  • 2019-03-01
  • FASEB Journal, Vol.33, pp.4314-4326
  • John Wiley and Sons Inc.
1 2 3 4 57